Interview with Peter van Tilburg, General Director / President, Cambridge Major…
It has now been 12 years since you co-founded ChemShop. One of the busiest, but probably most exciting moments in that period must have been the merger with CML in…
Address: Lage Mosten 33, 4822 NK, Noord-Brabant,Netherlands
Tel: +31-765731140
Web: http://www.ucbpharma.nl/home
As a global biopharma focused on severe diseases with operations in more than 40 countries and global revenue of € 3.1 billion in 2009, UCB aspires to be the patient-centric global biopharmaceutical leader transforming the lives of people living with severe diseases.
By integrating biology (bio) and chemistry (pharma), we can gain much deeper insights into disease pathways, including the complexities of severe diseases, as well as producing more potent, cost-effective drugs.
The unique combination of expertise in large, antibody-based molecules and small, chemically-derived molecules places us in a strong position to realise this ambition. Cimzia®, our New Biological Entity (NBE), targeted at Crohn’s disease and rheumatoid arthritis, is one of the first fruits of this synergy of biology and chemistry.
UCB’s medicines are making a real difference to the lives of people all over the world. Some of our products are among the leaders in their field.
Vimpat® (lacosamide): Epilepsy
Keppra® (levetiracetam): Epilepsy
Neupro® (rotigotine): Parkinson’s disease, Restless Legs Syndrome
Nootropil® (piracetam): Regulating cerebral functions
Metadate CD™ (methylphenidate HCl) (CII): Attention Deficit Hyperactivity Disorder (ADHD)
Cimzia® (certolizumab pegol): Crohn’s disease, Rheumatoid arthritis
Xyzal® (levocetirizine): Allergies
Zyrtec® (cetirizine):Allergies
Tussionex™ (hydrocodone polistirex and chlorpheniramine polistirex) (CIII): Respiratory disease
It has now been 12 years since you co-founded ChemShop. One of the busiest, but probably most exciting moments in that period must have been the merger with CML in…
As an expatriate executive, you seem to be fully integrated into the local community. Can you explain to our readers what brought you here to the Netherlands? The quick answer…
The Beurs van Berlage, conference centre in the heart of Amsterdam, dates back to the year 1903, and is a significant Dutch monument and unique event center that has become…
In addition to highlighting company strategies and strengths in our reports, we also like to get a feel for the leaders within the local markets that we cover. We noticed…
There is a very interesting history behind the origins of Top Institute Pharma (TI Pharma) as it aligned the interests of both the World Health Organization (Priority Medicines) and the…
Our meetings frequently bring us here to the Leiden Bio Science Park, but more often than not, to meet with younger, up-and-coming companies. HAL Allergy, meanwhile, has a rich and…
You are still relatively new to the Netherlands having been here for one year. This must be a very insightful experience abroad. What were your initial expectations and first impressions…
You began as managing director of this Dutch affiliate close to one year ago. What was the trajectory that led you to this position and what were your initial impressions…
Since its founding Galapagos has operated with a hybrid business model which has combined its internal discoveries with service activities. This model has worked quite well as it has now…
As much as this report is about business trends and insights, we also like to portray the personalities of the industry in the markets that we cover. What has been…
Shire has many offices in America, Europe, as well as in Singapore, in Japan and in Australia. The group has a vast global network and a strong presence in these…
Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega…
See our Cookie Privacy Policy Here
